Wega's knowledge & networking breakfast 1/2019

Patient Generated Data & Digital Biomarkers Transformation are Changing the Way We Work and Experiment. Digitalisation is transforming the way we live our lives in many different aspects, but healthcare and clinical trials remains one of the industry that still has not been impacted. This will definitely change as patients demand a more patient centric approach and the cost of conducting clinical trials become unsustainable. In this talk, Dr. Elin Haf Davies will provide some insight into the value of patient-generated data and digital biomarkers along with some a hands-on experience with supporting patients adopting such solutions. We will address relevant topics like: Why the drug development paradigm needs to change and innovate? How patient generated data and digital biomarkers offer a new opportunity for patient centricity and innovation in study design What are the risks - perceived and real How higher throughput and continuous timeline experiments become an everyday opportunity What are the regulatory, governance and compliance environment to be aware of During the session Elin Haf will also share operational and logistical experiences of conducting remote, decentralised, remote clinical trials.